Matches in Wikidata for { <http://www.wikidata.org/entity/Q64598059> ?p ?o ?g. }
Showing items 1 to 53 of
53
with 100 items per page.
- Q64598059 description "clinical trial" @default.
- Q64598059 description "ensayu clínicu" @default.
- Q64598059 description "klinisch onderzoek" @default.
- Q64598059 description "клінічне випробування" @default.
- Q64598059 description "կլինիկական փորձարկում" @default.
- Q64598059 name "Activity Study of Bevacizumab With Temozolomide ± Irinotecan for Neuroblastoma in Children" @default.
- Q64598059 type Item @default.
- Q64598059 label "Activity Study of Bevacizumab With Temozolomide ± Irinotecan for Neuroblastoma in Children" @default.
- Q64598059 prefLabel "Activity Study of Bevacizumab With Temozolomide ± Irinotecan for Neuroblastoma in Children" @default.
- Q64598059 P1050 Q64598059-13B1E39F-1950-4BBE-9437-E8B291732179 @default.
- Q64598059 P1132 Q64598059-4BF8338B-5169-41A2-93D5-B47501074642 @default.
- Q64598059 P1476 Q64598059-8AF94B81-A7B2-461F-A102-022FE9E88053 @default.
- Q64598059 P17 Q64598059-44F577E1-4CB6-4998-A8A7-47FB538F9183 @default.
- Q64598059 P17 Q64598059-73EFDF5B-9DA0-4C40-8E79-802E6E5637CA @default.
- Q64598059 P17 Q64598059-7E99B946-F3CC-4F6F-B9ED-FB89A429F683 @default.
- Q64598059 P17 Q64598059-95514426-7885-4F7A-A57B-578E0466BA0C @default.
- Q64598059 P17 Q64598059-C88C9375-7531-426C-8231-BF1D24959C0A @default.
- Q64598059 P17 Q64598059-D01D3D5F-2BDD-4EBE-A96F-70E5180B3109 @default.
- Q64598059 P17 Q64598059-DC3C8AF0-7C81-496B-8465-9203EBED9200 @default.
- Q64598059 P17 Q64598059-EFFA1F76-3C56-437B-AF0C-8F460E642176 @default.
- Q64598059 P1813 Q64598059-0F6341F8-5EFE-4F70-A76A-7F77ECE0BD1B @default.
- Q64598059 P3098 Q64598059-8EFE317F-3A95-42CF-987B-8B82536193A0 @default.
- Q64598059 P31 Q64598059-B98168EA-775C-4ADE-B03A-5ABC1960FB7C @default.
- Q64598059 P4135 Q64598059-2C094780-F029-4EEF-A396-2FEF2082AAF5 @default.
- Q64598059 P4844 Q64598059-6C76020A-600C-4C69-948A-0CDB458A8E13 @default.
- Q64598059 P4844 Q64598059-973C9C21-9A73-47A0-A705-A23CD2611057 @default.
- Q64598059 P580 Q64598059-1A286851-EDF4-4FE9-A723-591A951FD084 @default.
- Q64598059 P582 Q64598059-88121E10-A948-452E-8783-BCD1336568AF @default.
- Q64598059 P6099 Q64598059-4CAAC9DD-2D4B-4A2B-8A58-A39DBE1A3079 @default.
- Q64598059 P767 Q64598059-5AA71B51-33CB-44F0-9437-2E8AF1D30B39 @default.
- Q64598059 P8363 Q64598059-811C5484-7F72-4F7D-BF98-99858E4278F8 @default.
- Q64598059 P1050 Q938205 @default.
- Q64598059 P1132 "+160" @default.
- Q64598059 P1476 "A Randomised Phase IIb Trial of Bevacizumab Added to Temozolomide ± Irinotecan for Children With Refractory/Relapsed Neuroblastoma - BEACON-Neuroblastoma Trial" @default.
- Q64598059 P17 Q142 @default.
- Q64598059 P17 Q145 @default.
- Q64598059 P17 Q27 @default.
- Q64598059 P17 Q29 @default.
- Q64598059 P17 Q35 @default.
- Q64598059 P17 Q38 @default.
- Q64598059 P17 Q39 @default.
- Q64598059 P17 Q40 @default.
- Q64598059 P1813 "BEACON" @default.
- Q64598059 P3098 "NCT02308527" @default.
- Q64598059 P31 Q30612 @default.
- Q64598059 P4135 "+21" @default.
- Q64598059 P4844 Q412197 @default.
- Q64598059 P4844 Q413299 @default.
- Q64598059 P580 "2013-07-01T00:00:00Z" @default.
- Q64598059 P582 "2018-09-01T00:00:00Z" @default.
- Q64598059 P6099 Q42824440 @default.
- Q64598059 P767 Q62558396 @default.
- Q64598059 P8363 Q78089383 @default.